CO 2 -laser therapy in patients with vulvar intraepithelial neoplasia

Th J.M. Helmerhorst*, C. H. van der Vaart, G. H. Dijkhuizen, J. J. Calame, P. Kenemans, J. G. Stolk

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

It is generally accepted to consider vulvar intraepithelial neoplasia grade III(VIN III) a premalignant condition. The lesion is more frequently diagnosed in younger patients. Conventional surgical treatment is often mutilating and recurrence rates have been reported of approximately 30%. Laser vaporization is a promising alternative therapy. Ten patients with VIN III were treated with CO 2 laser. Two patients were retreated with laser for residual disease, and two patients for recurrent disease. One failure was observed, and one patient was off-study. In all patients excellent cosmetic results were obtained. Laser vaporization appears to be an effective and nonmutilating therapy, and preferable for young VIN patients.

Original languageEnglish
Pages (from-to)149-155
Number of pages7
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume34
Issue number1-2
DOIs
Publication statusPublished - 1 Jan 1990

Keywords

  • Laser
  • Vulvar intraepithelial neoplasia

Fingerprint

Dive into the research topics of 'CO 2 -laser therapy in patients with vulvar intraepithelial neoplasia'. Together they form a unique fingerprint.

Cite this